Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 454,885 |
|
|||||
| News | - | ||||||
| Day High | 64.96 | Low High |
|||||
| Day Low | 62.2335 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nuvalent Inc | NUVL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.73 | 2.76% | 64.49 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 63.00 | 62.2335 | 64.96 | 64.49 | 62.76 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,796 | 454,885 | $ 63.93 | $ 29,079,792 | - | 33.03 - 89.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:01:56 | priorref | 545 | $ 64.49 | USD |
Nuvalent Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.13B | 64.07M | - | 0 | -126.22M | -1.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nuvalent News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NUVL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 65.78 | 67.0147 | 61.795 | 63.80 | 744,605 | -1.29 | -1.96% |
| 1 Month | 77.49 | 78.22 | 61.795 | 68.81 | 638,321 | -13.00 | -16.78% |
| 3 Months | 76.34 | 89.39 | 61.795 | 76.61 | 486,312 | -11.85 | -15.52% |
| 6 Months | 50.37 | 89.39 | 49.02 | 71.48 | 482,876 | 14.12 | 28.03% |
| 1 Year | 34.53 | 89.39 | 33.03 | 60.01 | 477,117 | 29.96 | 86.77% |
| 3 Years | 18.10 | 89.39 | 7.09 | 44.34 | 305,199 | 46.39 | 256.30% |
| 5 Years | 18.10 | 89.39 | 7.09 | 44.34 | 305,199 | 46.39 | 256.30% |
Nuvalent Description
| Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. |
